Share on StockTwits
 

CONMED Corp. (NASDAQ:CNMD) will be issuing its quarterly earnings data on Thursday, February 13th. Parties interested in participating in the company’s conference call can do so using this link.

Several analysts have recently commented on the stock. Analysts at Needham & Company raised their price target on shares of CONMED Corp. from $45.00 to $48.00 in a research note on Tuesday. They now have a “buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of CONMED Corp. in a research note on Monday, November 25th. They now have a $41.00 price target on the stock.

CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.